World's Best Scientists 2026 revealed!

Overview

John J. Kavanagh was affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research covered several fields within medicine, with a focus on pulmonary and respiratory medicine and oncology, alongside contributions in mechanics of materials, aerospace engineering, and materials chemistry.

Their work often addressed a variety of topics, including:

  • Metal and Thin Film Mechanics
  • High-Temperature Coating Behaviors
  • Fusion materials and technologies
  • Ovarian cancer diagnosis and treatment
  • Lung Cancer Research Studies
  • Monoclonal and Polyclonal Antibodies Research
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Among their frequent co-authors were Xiao Tao, Xiaoying Li, Hanshan Dong, A. Matthews, and A. Leyland.

Their recent publications reflect a diverse range of research interests spanning materials science and clinical oncology. Papers include:

  • "An investigation of precipitation strengthened Inconel 718 superalloy after triode plasma nitriding," 2022, published in Surface and Coatings Technology
  • "Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer," 2020, published in International Journal of Gynecological Cancer
  • "SASP from lung senescent fibroblasts induces immunesenescence and fibrosis," 2020, published in The FASEB Journal
  • "Carcinoma secundário de mama por tumor metastático de ovário: relato de dois casos," 2022, published in Revista Brasileira de Cancerologia

The venues where John J. Kavanagh published included Surface and Coatings Technology, International Journal of Gynecological Cancer, The FASEB Journal, and Revista Brasileira de Cancerologia.

Best Publications

  • Anticancer therapy targeting the apoptotic pathway

    Wei Hu;John J Kavanagh

  • 13-cis-Retinoic Acid Plus Interferon α -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix

    Scott M. Lippman;John J. Kavanagh;Mario Paredes-Espinoza;Fernando Delgadillo-Madrueño

  • The taxoids: paclitaxel (Taxol®) and docetaxel (Taxotere®)☆

    Richard Pazdur;Andrzej P. Kudelka;John J. Kavanagh;Philip R. Cohen

  • Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin.

    D M Gershenson;M Morris;A Cangir;J J Kavanagh

  • Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma.

    A. P. Kudelka;D. Tresukosol;C. L. Edwards;R. S. Freedman

  • Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.

    David M. Gershenson;Charlotte C. Sun;Diane Bodurka;Robert L. Coleman

  • An Assessment of the Utilization of Complementary and Alternative Medication in Women With Gynecologic or Breast Malignancies

    Marisa A. Navo;Julie Phan;Christy Vaughan;J. Lynn Palmer

  • Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.

    J H Lee;J J Kavanagh;D M Wildrick;J T Wharton

  • Recombinant Human Thrombopoietin Attenuates Carboplatin-Induced Severe Thrombocytopenia and the Need for Platelet Transfusions in Patients with Gynecologic Cancer

    Saroj Vadhan-Raj;Claire F. Verschraegen;Carlos Bueso-Ramos;Carlos Bueso-Ramos;Hal E. Broxmeyer

  • Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

    Siqing Fu;Wei Hu;Revathy Iyer;John J. Kavanagh

  • Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum

    David M. Gershenson;Charlotte C. Sun;Revathy B. Iyer;Anais L. Malpica

  • Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.

    E. G. Hanania;R. E. Giles;J. Kavanagh;D. Ellerson

  • GnRH antagonists in the treatment of gynecological and breast cancers.

    G Emons;C Gründker;A R Günthert;S Westphalen

  • Identification of an IL-10-Producing HLA-DR-Negative Monocyte Subset in the Malignant Ascites of Patients with Ovarian Carcinoma That Inhibits Cytokine Protein Expression and Proliferation of Autologous T Cells

    Amy E. Loercher;Micheal A. Nash;John J. Kavanagh;Chris D. Platsoucas

  • A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix.

    Andrzej P. Kudelka;Tally Levy;Claire F. Verschraegen;Creighton L. Edwards

  • Efficacy and safety of liposomal anthracyclines in Phase I/II clinical trials

    David S. Alberts;Franco M. Muggia;James Carmichael;Eric P. Winer

  • Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix

    C. F. Verschraegen;T. Levy;A. P. Kudelka;E. Llerena

  • Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later

    C. F. Verschraegen;M. Benjapibal;W. Supakarapongkul;L. B. Levy

  • Ovarian cancer, the coagulation pathway, and inflammation

    Xipeng Wang;Ena Wang;John J Kavanagh;Ralph S Freedman

  • Staging Classifications and Clinical Practice: Guidelines for Gynaecologic Cancers

    JL Benedet;Sergio Pecorelli;Hextan Ys Ngan;Lynne Denny

Frequent Co-Authors

David M. Gershenson
David M. Gershenson The University of Texas MD Anderson Cancer Center
Elvio G. Silva
Elvio G. Silva The University of Texas MD Anderson Cancer Center
Robert C. Bast
Robert C. Bast The University of Texas MD Anderson Cancer Center
Scott M. Lippman
Scott M. Lippman University of California, San Diego
Michael T. Deavers
Michael T. Deavers Houston Methodist
Robert L. Coleman
Robert L. Coleman The University of Texas MD Anderson Cancer Center
Albert B. Deisseroth
Albert B. Deisseroth US Food and Drug Administration
Anais Malpica
Anais Malpica The University of Texas MD Anderson Cancer Center
Anil K. Sood
Anil K. Sood The University of Texas MD Anderson Cancer Center
Pedro Tomas Ramirez
Pedro Tomas Ramirez The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare but not ready for the commitment of a full medical degree, many rewarding alternatives exist. Numerous accredited online programs equip students for vital healthcare roles—often with flexible schedules and accessible admissions.

For example, those seeking administrative roles can find excellent options with a health care administration degree. These programs prepare graduates for leadership positions in hospitals and clinics, often in under four years.

If you prefer direct patient care, becoming an LPN or RN is a popular pathway. Some schools offer lpn school without teas test requirements, making entry less stressful for prospective students. For current RNs seeking career advancement, there are many convenient rn to np programs online that bridge the gap to Nurse Practitioner roles.

If you’re interested in the technical side of healthcare, financial aid for medical billing and coding programs can help you break into this fast-growing field, often with lower tuition costs and flexible payment options.

Best Scientists Citing John J. Kavanagh

Recently Published Articles